欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2025, Vol. 25 ›› Issue (04): 232-238.DOI: 10.3969/j.issn.1009-976X.2025.04.004

• 论著与临床研究 • 上一篇    下一篇

TGFβ1基因介导“健肾壮骨汤”调控成骨细胞Wnt3a/β-catenin信号通路

张镇锋, 陈健聪, 张勋, 王国亮*   

  1. 广州市开发区医院骨科,广东广州 510730
  • 通讯作者: *王国亮,Email:wglrl@163.com
  • 基金资助:
    广东省中医药局科研项目(编号:20231250)

Jianshen Zhuanggu Tang targets TGF β Gene in regulation of Wnt3a/β-catenin signaling pathway on osteoblasts

ZHANG Zhen-feng, CHEN Jian-cong, ZHANG Xun, WANG Guo-liang   

  1. Department of Orthopedics, Guangzhou Development District Hospital, Guangzhou 510730, China
  • Published:2025-09-26
  • Contact: WANG Guo-liang, wglrl@163.com

摘要: 目的 探讨TGFβ1介导“健肾壮骨汤”调控Wnt3a/β-catenin信号通路对成骨细胞的作用机制和影响。方法 “健肾壮骨汤”和Wnt3a/β-catenin信号通路抑制剂DKK1共孵育C518、MC3T3-E1成骨细胞株,检测细胞中的Wnt3a、TGFβ1、OPG和RANKL mRNA和蛋白表达水平,并进行挽救实验、RNA-seq测序分析。结果 DKK1处理C518、MC3T3-E1细胞后,TGFβ1、OPG和RANKL表达水平显著下调(P<0.05)。DKK1干预使sh TGFβ1组和TGFβ1OE组Wnt3a、TGFβ1、OPG和RANKL的mRNA及蛋白表达水平均显著下调(P<0.05)。在C518细胞模型中,当OPG基因被敲低后,TGFβ1促进OPG表达的作用被抑制;而“健肾壮骨汤”干预能够恢复TGFβ1对OPG表达的促进作用。RNA-seq结果显示TGFβ1、OPG和RANKL为显著差异基因。结论 TGFβ1基因介导“健肾壮骨汤”调控Wnt3a/β-catenin信号通路调控OPG/RANKL表达,TGFβ1基因可能是治疗骨质疏松的重要靶点。

关键词: TGFβ1基因, “健肾壮骨汤”, Wnt3a/β-catenin信号通路

Abstract: Objective To investigate the mechanism and effect of TGFβ1-mediated Jianshen Zhuanggu Tang (JSZGT) in regulating the Wnt3a/β-catenin signaling pathway on osteoblasts. Methods Osteoblast cell lines C518 and MC3T3-E1 were co-incubated with JSZGT and DKK1 (an inhibitor of the Wnt3a/β-catenin signaling pathway). The differences in mRNA and protein levels of Wnt3a, TGFβ1, OPG, and RANKL in the cells were detected, and rescue experiments and RNA-seq analysis were conducted. Results After treating C518 and MC3T3-E1 cells with DKK1, the expression levels of TGFβ1, OPG, and RANKL were significantly downregulated (P<0.05). DKK1 significantly reduced the mRNA and protein levels of Wnt3a, TGFβ1, OPG, and RANKL in both the sh TGFβ1 group and the TGFβ1 overexpression (TGFβ1OE) group (P<0.05). In the C518 cell model, the knocked down expression of OPG gene inhibited the promoting effect of TGFβ1 on OPG expression; however, JSZGT treatment could restore this promoting effect of TGFβ1 on OPG expression. RNA-Seq results showed that TGFβ1, OPG, and RANKL were significantly differentially expressed genes. Conclusion The TGFβ1 gene mediates JSZGT to regulate the Wnt3a/β-catenin signaling pathway and thus modulate the expression of OPG/RANKL. The TGFβ1 gene may be an important target for the treatment of osteoporosis.

Key words: TGFβ1, Jianshen Zhuanggu Tang, Wnt3a/β-catenin signaling pathway

中图分类号: